ALMS · Forms 3, 4, 5
Insider trades at ALUMIS INC.
7 insiders sold $1.4M and 1 insider bought $10.7M of ALUMIS INC. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for ALUMIS INC. (ALMS) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Srinivas Akkaraju | Director | Sell | 48,066 | $10.55 | $507K | Form 4 | |
| Srinivas Akkaraju | Director | Sell | 48,065 | $10.55 | $507K | Form 4 | |
| Srinivas Akkaraju | Director | Buy | 273,291 | $10.63 | $2.9M | Form 4 | |
| Srinivas Akkaraju | Director | Buy | 273,290 | $10.63 | $2.9M | Form 4 | |
| Srinivas Akkaraju | Director | Buy | 220,070 | $11.17 | $2.5M | Form 4 | |
| Srinivas Akkaraju | Director | Buy | 220,070 | $11.17 | $2.5M | Form 4 | |
| John R. Schroer | Chief Financial Officer | Sell | 3,282 | $26.37 | $87K | Form 4 | |
| Sanam Pangali | Chief Legal Officer | Sell | 1,364 | $26.37 | $36K | Form 4 | |
| Roy C. Hardiman | Chief Business & Strategy Ofcr | Sell | 2,692 | $26.37 | $71K | Form 4 | |
| David M Goldstein | Chief Scientific Officer | Sell | 2,596 | $26.37 | $68K | Form 4 | |
| Jorn Drappa | Chief Medical Officer | Sell | 2,447 | $26.37 | $65K | Form 4 | |
| Mark Christopher Bradley | Chief Development Officer | Sell | 2,572 | $26.37 | $68K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.